The state of clinical art of the coagulopathy of cirrhosis changed considerably over the last decade. Until 2005, cirrhosis was considered as the epitome of the hemorrhagic coagulopathies and the abnormal hemostasis tests associated with the disease were corrected with infusion of fresh frozen plasma or platelets to minimize the risk of bleeding. Since that time, a great deal of work has been done and there is now a change of paradigm. The prothrombin time once considered as an isolated measure of bleeding risk was rejected, and cirrhosis shifted from a purely hemorrhagic construct to a mixed and thrombosis-prone paradigm. In this article we examine the interesting history of how these conceptual changes came about.

Changing Concepts of Cirrhotic Coagulopathy / A. Tripodi, M. Primignani, P.M. Mannucci, S.H. Caldwell. - In: THE AMERICAN JOURNAL OF GASTROENTEROLOGY. - ISSN 0002-9270. - 112:2(2017), pp. 274-281. [10.1038/ajg.2016.498]

Changing Concepts of Cirrhotic Coagulopathy

A. Tripodi
;
2017

Abstract

The state of clinical art of the coagulopathy of cirrhosis changed considerably over the last decade. Until 2005, cirrhosis was considered as the epitome of the hemorrhagic coagulopathies and the abnormal hemostasis tests associated with the disease were corrected with infusion of fresh frozen plasma or platelets to minimize the risk of bleeding. Since that time, a great deal of work has been done and there is now a change of paradigm. The prothrombin time once considered as an isolated measure of bleeding risk was rejected, and cirrhosis shifted from a purely hemorrhagic construct to a mixed and thrombosis-prone paradigm. In this article we examine the interesting history of how these conceptual changes came about.
international normalized ratio; recombinant factor VIIA; stage liver-disease; portal-vein thrombosis; conventional coagulation tests; increased plasma fibrinolysis; arachidonic-acid metabilism; prolonged bleeding-time; controlled-trial; activatable fibrinolysis
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
2017
1-nov-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
0389.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 205.81 kB
Formato Adobe PDF
205.81 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/481480
Citazioni
  • ???jsp.display-item.citation.pmc??? 51
  • Scopus 138
  • ???jsp.display-item.citation.isi??? 126
social impact